Tianjin Tianyao Pharmaceuticals Hits Day Low of CNY 5.81 Amid Price Pressure

Tianjin Tianyao Pharmaceuticals Co., Ltd. experienced significant activity today, with the stock declining by 9.92% and reaching an intraday low of CNY 5.81. This drop comes amid a challenging performance landscape, as the company has reported negative results for the last two consecutive quarters, including a notable decline in profit before tax of 16.45%. In terms of financial metrics, the company has shown a low Return on Capital Employed (ROCE) of 4.51%, indicating limited profitability relative to its capital. Over the past five years, net sales have contracted at an annual rate of 0.13%, while operating profit has decreased by 8.32%. The stock's performance over the past year has also been underwhelming, generating a return of -2.81%, which is below the China Shanghai Composite's performance. Despite a market capitalization of CNY 5,645 million, Tianjin Tianyao's valuation appears high with a Price to Earnings (P/E) ratio of 91.00 and a Price to Book ratio of 1.85. The company’s dividend yield stands at 1.90%, reflecting its current financial challenges.